ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Ggrade Probiotics Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-32O11372
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Ggrade Probiotics Market Research Report 2022
BUY CHAPTERS

Global Pharmaceutical Ggrade Probiotics Market Research Report 2024

Code: QYRE-Auto-32O11372
Report
October 2024
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
DuPont (Danisco)
Chr. Hansen
Lallemand
China-Biotics
Nestle S A
Danone
Probi AB
BioGaia
Yakult
Novozymes
Valio
Glory Biotech
Greentech
Bioriginal
Biosearch Life

Pharmaceutical Ggrade Probiotics Market Size

The global Pharmaceutical Ggrade Probiotics market was valued at US$ 70 million in 2023 and is anticipated to reach US$ 92 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.

Pharmaceutical Ggrade Probiotics Market

Pharmaceutical Ggrade Probiotics Market

North American market for Pharmaceutical Ggrade Probiotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pharmaceutical Ggrade Probiotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Pharmaceutical Ggrade Probiotics include DuPont (Danisco), Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia and Yakult, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Ggrade Probiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Ggrade Probiotics.

Report Scope

The Pharmaceutical Ggrade Probiotics market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Ggrade Probiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Ggrade Probiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Ggrade Probiotics Market Report

Report Metric Details
Report Name Pharmaceutical Ggrade Probiotics Market
Accounted market size in 2023 US$ 70 million
Forecasted market size in 2030 US$ 92 million
CAGR 4.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Bifidobacterium
  • Lactobacillus
  • Others
Segment by Application
  • Nutraceuticals
  • Dietary Supplements
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company DuPont (Danisco), Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia, Yakult, Novozymes, Valio, Glory Biotech, Greentech, Bioriginal, Biosearch Life
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharmaceutical Ggrade Probiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pharmaceutical Ggrade Probiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Ggrade Probiotics Market growing?

Ans: The Pharmaceutical Ggrade Probiotics Market witnessing a CAGR of 4.0% during the forecast period 2024-2030.

What is the Pharmaceutical Ggrade Probiotics Market size in 2030?

Ans: The Pharmaceutical Ggrade Probiotics Market size in 2030 will be US$ 92 million.

Who are the main players in the Pharmaceutical Ggrade Probiotics Market report?

Ans: The main players in the Pharmaceutical Ggrade Probiotics Market are DuPont (Danisco), Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi, BioGaia, Yakult, Novozymes, Valio, Glory Biotech, Greentech, Bioriginal, Biosearch Life

What are the Application segmentation covered in the Pharmaceutical Ggrade Probiotics Market report?

Ans: The Applications covered in the Pharmaceutical Ggrade Probiotics Market report are Nutraceuticals, Dietary Supplements, Others

What are the Type segmentation covered in the Pharmaceutical Ggrade Probiotics Market report?

Ans: The Types covered in the Pharmaceutical Ggrade Probiotics Market report are Bifidobacterium, Lactobacillus, Others

1 Pharmaceutical Ggrade Probiotics Market Overview
1.1 Product Overview and Scope of Pharmaceutical Ggrade Probiotics
1.2 Pharmaceutical Ggrade Probiotics Segment by Type
1.2.1 Global Pharmaceutical Ggrade Probiotics Market Value Comparison by Type (2024-2030)
1.2.2 Bifidobacterium
1.2.3 Lactobacillus
1.2.4 Others
1.3 Pharmaceutical Ggrade Probiotics Segment by Application
1.3.1 Global Pharmaceutical Ggrade Probiotics Market Value by Application: (2024-2030)
1.3.2 Nutraceuticals
1.3.3 Dietary Supplements
1.3.4 Others
1.4 Global Pharmaceutical Ggrade Probiotics Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Ggrade Probiotics Revenue 2019-2030
1.4.2 Global Pharmaceutical Ggrade Probiotics Sales 2019-2030
1.4.3 Global Pharmaceutical Ggrade Probiotics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharmaceutical Ggrade Probiotics Market Competition by Manufacturers
2.1 Global Pharmaceutical Ggrade Probiotics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pharmaceutical Ggrade Probiotics Average Price by Manufacturers (2019-2024)
2.4 Global Pharmaceutical Ggrade Probiotics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Ggrade Probiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Ggrade Probiotics, Product Type & Application
2.7 Pharmaceutical Ggrade Probiotics Market Competitive Situation and Trends
2.7.1 Pharmaceutical Ggrade Probiotics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Ggrade Probiotics Players Market Share by Revenue
2.7.3 Global Pharmaceutical Ggrade Probiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Ggrade Probiotics Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Ggrade Probiotics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharmaceutical Ggrade Probiotics Global Pharmaceutical Ggrade Probiotics Sales by Region: 2019-2030
3.2.1 Global Pharmaceutical Ggrade Probiotics Sales by Region: 2019-2024
3.2.2 Global Pharmaceutical Ggrade Probiotics Sales by Region: 2025-2030
3.3 Global Pharmaceutical Ggrade Probiotics Global Pharmaceutical Ggrade Probiotics Revenue by Region: 2019-2030
3.3.1 Global Pharmaceutical Ggrade Probiotics Revenue by Region: 2019-2024
3.3.2 Global Pharmaceutical Ggrade Probiotics Revenue by Region: 2025-2030
3.4 North America Pharmaceutical Ggrade Probiotics Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Ggrade Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharmaceutical Ggrade Probiotics Sales by Country (2019-2030)
3.4.3 North America Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Ggrade Probiotics Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Ggrade Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharmaceutical Ggrade Probiotics Sales by Country (2019-2030)
3.5.3 Europe Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Ggrade Probiotics Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Ggrade Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharmaceutical Ggrade Probiotics Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharmaceutical Ggrade Probiotics Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Ggrade Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharmaceutical Ggrade Probiotics Sales by Country (2019-2030)
3.7.3 Latin America Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Ggrade Probiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Ggrade Probiotics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharmaceutical Ggrade Probiotics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Ggrade Probiotics Sales by Type (2019-2030)
4.1.1 Global Pharmaceutical Ggrade Probiotics Sales by Type (2019-2024)
4.1.2 Global Pharmaceutical Ggrade Probiotics Sales by Type (2025-2030)
4.1.3 Global Pharmaceutical Ggrade Probiotics Sales Market Share by Type (2019-2030)
4.2 Global Pharmaceutical Ggrade Probiotics Revenue by Type (2019-2030)
4.2.1 Global Pharmaceutical Ggrade Probiotics Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Ggrade Probiotics Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Type (2019-2030)
4.3 Global Pharmaceutical Ggrade Probiotics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharmaceutical Ggrade Probiotics Sales by Application (2019-2030)
5.1.1 Global Pharmaceutical Ggrade Probiotics Sales by Application (2019-2024)
5.1.2 Global Pharmaceutical Ggrade Probiotics Sales by Application (2025-2030)
5.1.3 Global Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2019-2030)
5.2 Global Pharmaceutical Ggrade Probiotics Revenue by Application (2019-2030)
5.2.1 Global Pharmaceutical Ggrade Probiotics Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Ggrade Probiotics Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Application (2019-2030)
5.3 Global Pharmaceutical Ggrade Probiotics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 DuPont (Danisco)
6.1.1 DuPont (Danisco) Corporation Information
6.1.2 DuPont (Danisco) Description and Business Overview
6.1.3 DuPont (Danisco) Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 DuPont (Danisco) Pharmaceutical Ggrade Probiotics Product Portfolio
6.1.5 DuPont (Danisco) Recent Developments/Updates
6.2 Chr. Hansen
6.2.1 Chr. Hansen Corporation Information
6.2.2 Chr. Hansen Description and Business Overview
6.2.3 Chr. Hansen Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Chr. Hansen Pharmaceutical Ggrade Probiotics Product Portfolio
6.2.5 Chr. Hansen Recent Developments/Updates
6.3 Lallemand
6.3.1 Lallemand Corporation Information
6.3.2 Lallemand Description and Business Overview
6.3.3 Lallemand Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Lallemand Pharmaceutical Ggrade Probiotics Product Portfolio
6.3.5 Lallemand Recent Developments/Updates
6.4 China-Biotics
6.4.1 China-Biotics Corporation Information
6.4.2 China-Biotics Description and Business Overview
6.4.3 China-Biotics Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China-Biotics Pharmaceutical Ggrade Probiotics Product Portfolio
6.4.5 China-Biotics Recent Developments/Updates
6.5 Nestle
6.5.1 Nestle Corporation Information
6.5.2 Nestle Description and Business Overview
6.5.3 Nestle Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nestle Pharmaceutical Ggrade Probiotics Product Portfolio
6.5.5 Nestle Recent Developments/Updates
6.6 Danone
6.6.1 Danone Corporation Information
6.6.2 Danone Description and Business Overview
6.6.3 Danone Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Danone Pharmaceutical Ggrade Probiotics Product Portfolio
6.6.5 Danone Recent Developments/Updates
6.7 Probi
6.6.1 Probi Corporation Information
6.6.2 Probi Description and Business Overview
6.6.3 Probi Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Probi Pharmaceutical Ggrade Probiotics Product Portfolio
6.7.5 Probi Recent Developments/Updates
6.8 BioGaia
6.8.1 BioGaia Corporation Information
6.8.2 BioGaia Description and Business Overview
6.8.3 BioGaia Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioGaia Pharmaceutical Ggrade Probiotics Product Portfolio
6.8.5 BioGaia Recent Developments/Updates
6.9 Yakult
6.9.1 Yakult Corporation Information
6.9.2 Yakult Description and Business Overview
6.9.3 Yakult Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yakult Pharmaceutical Ggrade Probiotics Product Portfolio
6.9.5 Yakult Recent Developments/Updates
6.10 Novozymes
6.10.1 Novozymes Corporation Information
6.10.2 Novozymes Description and Business Overview
6.10.3 Novozymes Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novozymes Pharmaceutical Ggrade Probiotics Product Portfolio
6.10.5 Novozymes Recent Developments/Updates
6.11 Valio
6.11.1 Valio Corporation Information
6.11.2 Valio Pharmaceutical Ggrade Probiotics Description and Business Overview
6.11.3 Valio Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Valio Pharmaceutical Ggrade Probiotics Product Portfolio
6.11.5 Valio Recent Developments/Updates
6.12 Glory Biotech
6.12.1 Glory Biotech Corporation Information
6.12.2 Glory Biotech Pharmaceutical Ggrade Probiotics Description and Business Overview
6.12.3 Glory Biotech Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Glory Biotech Pharmaceutical Ggrade Probiotics Product Portfolio
6.12.5 Glory Biotech Recent Developments/Updates
6.13 Greentech
6.13.1 Greentech Corporation Information
6.13.2 Greentech Pharmaceutical Ggrade Probiotics Description and Business Overview
6.13.3 Greentech Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Greentech Pharmaceutical Ggrade Probiotics Product Portfolio
6.13.5 Greentech Recent Developments/Updates
6.14 Bioriginal
6.14.1 Bioriginal Corporation Information
6.14.2 Bioriginal Pharmaceutical Ggrade Probiotics Description and Business Overview
6.14.3 Bioriginal Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bioriginal Pharmaceutical Ggrade Probiotics Product Portfolio
6.14.5 Bioriginal Recent Developments/Updates
6.15 Biosearch Life
6.15.1 Biosearch Life Corporation Information
6.15.2 Biosearch Life Pharmaceutical Ggrade Probiotics Description and Business Overview
6.15.3 Biosearch Life Pharmaceutical Ggrade Probiotics Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Biosearch Life Pharmaceutical Ggrade Probiotics Product Portfolio
6.15.5 Biosearch Life Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Ggrade Probiotics Industry Chain Analysis
7.2 Pharmaceutical Ggrade Probiotics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Ggrade Probiotics Production Mode & Process
7.4 Pharmaceutical Ggrade Probiotics Sales and Marketing
7.4.1 Pharmaceutical Ggrade Probiotics Sales Channels
7.4.2 Pharmaceutical Ggrade Probiotics Distributors
7.5 Pharmaceutical Ggrade Probiotics Customers
8 Pharmaceutical Ggrade Probiotics Market Dynamics
8.1 Pharmaceutical Ggrade Probiotics Industry Trends
8.2 Pharmaceutical Ggrade Probiotics Market Drivers
8.3 Pharmaceutical Ggrade Probiotics Market Challenges
8.4 Pharmaceutical Ggrade Probiotics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
DuPont (Danisco)
Chr. Hansen
Lallemand
China-Biotics
Nestle S A
Danone
Probi AB
BioGaia
Yakult
Novozymes
Valio
Glory Biotech
Greentech
Bioriginal
Biosearch Life
List of Tables
    Table 1. Global Pharmaceutical Ggrade Probiotics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Pharmaceutical Ggrade Probiotics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Pharmaceutical Ggrade Probiotics Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Pharmaceutical Ggrade Probiotics Sales (MT) of Key Manufacturers (2019-2024)
    Table 5. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Pharmaceutical Ggrade Probiotics Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Pharmaceutical Ggrade Probiotics Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Pharmaceutical Ggrade Probiotics Average Price (US$/MT) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Pharmaceutical Ggrade Probiotics, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Pharmaceutical Ggrade Probiotics, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Pharmaceutical Ggrade Probiotics, Product Type & Application
    Table 12. Global Key Manufacturers of Pharmaceutical Ggrade Probiotics, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Pharmaceutical Ggrade Probiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Ggrade Probiotics as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Pharmaceutical Ggrade Probiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Pharmaceutical Ggrade Probiotics Sales by Region (2019-2024) & (MT)
    Table 18. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Region (2019-2024)
    Table 19. Global Pharmaceutical Ggrade Probiotics Sales by Region (2025-2030) & (MT)
    Table 20. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Region (2025-2030)
    Table 21. Global Pharmaceutical Ggrade Probiotics Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Region (2019-2024)
    Table 23. Global Pharmaceutical Ggrade Probiotics Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Region (2025-2030)
    Table 25. North America Pharmaceutical Ggrade Probiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Pharmaceutical Ggrade Probiotics Sales by Country (2019-2024) & (MT)
    Table 27. North America Pharmaceutical Ggrade Probiotics Sales by Country (2025-2030) & (MT)
    Table 28. North America Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Pharmaceutical Ggrade Probiotics Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Pharmaceutical Ggrade Probiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Pharmaceutical Ggrade Probiotics Sales by Country (2019-2024) & (MT)
    Table 32. Europe Pharmaceutical Ggrade Probiotics Sales by Country (2025-2030) & (MT)
    Table 33. Europe Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Pharmaceutical Ggrade Probiotics Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Pharmaceutical Ggrade Probiotics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Pharmaceutical Ggrade Probiotics Sales by Region (2019-2024) & (MT)
    Table 37. Asia Pacific Pharmaceutical Ggrade Probiotics Sales by Region (2025-2030) & (MT)
    Table 38. Asia Pacific Pharmaceutical Ggrade Probiotics Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Pharmaceutical Ggrade Probiotics Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Pharmaceutical Ggrade Probiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Pharmaceutical Ggrade Probiotics Sales by Country (2019-2024) & (MT)
    Table 42. Latin America Pharmaceutical Ggrade Probiotics Sales by Country (2025-2030) & (MT)
    Table 43. Latin America Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Pharmaceutical Ggrade Probiotics Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Country (2019-2024) & (MT)
    Table 47. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales by Country (2025-2030) & (MT)
    Table 48. Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Pharmaceutical Ggrade Probiotics Sales (MT) by Type (2019-2024)
    Table 51. Global Pharmaceutical Ggrade Probiotics Sales (MT) by Type (2025-2030)
    Table 52. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Type (2019-2024)
    Table 53. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Type (2025-2030)
    Table 54. Global Pharmaceutical Ggrade Probiotics Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Pharmaceutical Ggrade Probiotics Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Type (2019-2024)
    Table 57. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Type (2025-2030)
    Table 58. Global Pharmaceutical Ggrade Probiotics Price (US$/MT) by Type (2019-2024)
    Table 59. Global Pharmaceutical Ggrade Probiotics Price (US$/MT) by Type (2025-2030)
    Table 60. Global Pharmaceutical Ggrade Probiotics Sales (MT) by Application (2019-2024)
    Table 61. Global Pharmaceutical Ggrade Probiotics Sales (MT) by Application (2025-2030)
    Table 62. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2019-2024)
    Table 63. Global Pharmaceutical Ggrade Probiotics Sales Market Share by Application (2025-2030)
    Table 64. Global Pharmaceutical Ggrade Probiotics Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Pharmaceutical Ggrade Probiotics Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Application (2019-2024)
    Table 67. Global Pharmaceutical Ggrade Probiotics Revenue Market Share by Application (2025-2030)
    Table 68. Global Pharmaceutical Ggrade Probiotics Price (US$/MT) by Application (2019-2024)
    Table 69. Global Pharmaceutical Ggrade Probiotics Price (US$/MT) by Application (2025-2030)
    Table 70. DuPont (Danisco) Corporation Information
    Table 71. DuPont (Danisco) Description and Business Overview
    Table 72. DuPont (Danisco) Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 73. DuPont (Danisco) Pharmaceutical Ggrade Probiotics Product
    Table 74. DuPont (Danisco) Recent Developments/Updates
    Table 75. Chr. Hansen Corporation Information
    Table 76. Chr. Hansen Description and Business Overview
    Table 77. Chr. Hansen Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 78. Chr. Hansen Pharmaceutical Ggrade Probiotics Product
    Table 79. Chr. Hansen Recent Developments/Updates
    Table 80. Lallemand Corporation Information
    Table 81. Lallemand Description and Business Overview
    Table 82. Lallemand Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 83. Lallemand Pharmaceutical Ggrade Probiotics Product
    Table 84. Lallemand Recent Developments/Updates
    Table 85. China-Biotics Corporation Information
    Table 86. China-Biotics Description and Business Overview
    Table 87. China-Biotics Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 88. China-Biotics Pharmaceutical Ggrade Probiotics Product
    Table 89. China-Biotics Recent Developments/Updates
    Table 90. Nestle Corporation Information
    Table 91. Nestle Description and Business Overview
    Table 92. Nestle Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 93. Nestle Pharmaceutical Ggrade Probiotics Product
    Table 94. Nestle Recent Developments/Updates
    Table 95. Danone Corporation Information
    Table 96. Danone Description and Business Overview
    Table 97. Danone Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 98. Danone Pharmaceutical Ggrade Probiotics Product
    Table 99. Danone Recent Developments/Updates
    Table 100. Probi Corporation Information
    Table 101. Probi Description and Business Overview
    Table 102. Probi Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 103. Probi Pharmaceutical Ggrade Probiotics Product
    Table 104. Probi Recent Developments/Updates
    Table 105. BioGaia Corporation Information
    Table 106. BioGaia Description and Business Overview
    Table 107. BioGaia Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 108. BioGaia Pharmaceutical Ggrade Probiotics Product
    Table 109. BioGaia Recent Developments/Updates
    Table 110. Yakult Corporation Information
    Table 111. Yakult Description and Business Overview
    Table 112. Yakult Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 113. Yakult Pharmaceutical Ggrade Probiotics Product
    Table 114. Yakult Recent Developments/Updates
    Table 115. Novozymes Corporation Information
    Table 116. Novozymes Description and Business Overview
    Table 117. Novozymes Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 118. Novozymes Pharmaceutical Ggrade Probiotics Product
    Table 119. Novozymes Recent Developments/Updates
    Table 120. Valio Corporation Information
    Table 121. Valio Description and Business Overview
    Table 122. Valio Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 123. Valio Pharmaceutical Ggrade Probiotics Product
    Table 124. Valio Recent Developments/Updates
    Table 125. Glory Biotech Corporation Information
    Table 126. Glory Biotech Description and Business Overview
    Table 127. Glory Biotech Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 128. Glory Biotech Pharmaceutical Ggrade Probiotics Product
    Table 129. Glory Biotech Recent Developments/Updates
    Table 130. Greentech Corporation Information
    Table 131. Greentech Description and Business Overview
    Table 132. Greentech Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 133. Greentech Pharmaceutical Ggrade Probiotics Product
    Table 134. Greentech Recent Developments/Updates
    Table 135. Bioriginal Corporation Information
    Table 136. Bioriginal Description and Business Overview
    Table 137. Bioriginal Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 138. Bioriginal Pharmaceutical Ggrade Probiotics Product
    Table 139. Bioriginal Recent Developments/Updates
    Table 140. Biosearch Life Corporation Information
    Table 141. Biosearch Life Description and Business Overview
    Table 142. Biosearch Life Pharmaceutical Ggrade Probiotics Sales (MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2019-2024)
    Table 143. Biosearch Life Pharmaceutical Ggrade Probiotics Product
    Table 144. Biosearch Life Recent Developments/Updates
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Pharmaceutical Ggrade Probiotics Distributors List
    Table 148. Pharmaceutical Ggrade Probiotics Customers List
    Table 149. Pharmaceutical Ggrade Probiotics Market Trends
    Table 150. Pharmaceutical Ggrade Probiotics Market Drivers
    Table 151. Pharmaceutical Ggrade Probiotics Market Challenges
    Table 152. Pharmaceutical Ggrade Probiotics Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Pharmaceutical Ggrade Probiotics
    Figure 2. Global Pharmaceutical Ggrade Probiotics Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Pharmaceutical Ggrade Probiotics Market Share by Type in 2023 & 2030
    Figure 4. Bifidobacterium Product Picture
    Figure 5. Lactobacillus Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Pharmaceutical Ggrade Probiotics Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Pharmaceutical Ggrade Probiotics Market Share by Application in 2023 & 2030
    Figure 9. Nutraceuticals
    Figure 10. Dietary Supplements
    Figure 11. Others
    Figure 12. Global Pharmaceutical Ggrade Probiotics Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Pharmaceutical Ggrade Probiotics Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Pharmaceutical Ggrade Probiotics Sales (2019-2030) & (MT)
    Figure 15. Global Pharmaceutical Ggrade Probiotics Average Price (US$/MT) & (2019-2030)
    Figure 16. Pharmaceutical Ggrade Probiotics Report Years Considered
    Figure 17. Pharmaceutical Ggrade Probiotics Sales Share by Manufacturers in 2023
    Figure 18. Global Pharmaceutical Ggrade Probiotics Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Pharmaceutical Ggrade Probiotics Players: Market Share by Revenue in 2023
    Figure 20. Pharmaceutical Ggrade Probiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Pharmaceutical Ggrade Probiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Pharmaceutical Ggrade Probiotics Sales Market Share by Country (2019-2030)
    Figure 23. North America Pharmaceutical Ggrade Probiotics Revenue Market Share by Country (2019-2030)
    Figure 24. United States Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Pharmaceutical Ggrade Probiotics Sales Market Share by Country (2019-2030)
    Figure 27. Europe Pharmaceutical Ggrade Probiotics Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Pharmaceutical Ggrade Probiotics Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Pharmaceutical Ggrade Probiotics Revenue Market Share by Region (2019-2030)
    Figure 35. China Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Pharmaceutical Ggrade Probiotics Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Pharmaceutical Ggrade Probiotics Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Pharmaceutical Ggrade Probiotics Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Pharmaceutical Ggrade Probiotics Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Pharmaceutical Ggrade Probiotics Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Pharmaceutical Ggrade Probiotics by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Pharmaceutical Ggrade Probiotics by Type (2019-2030)
    Figure 56. Global Pharmaceutical Ggrade Probiotics Price (US$/MT) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Pharmaceutical Ggrade Probiotics by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Pharmaceutical Ggrade Probiotics by Application (2019-2030)
    Figure 59. Global Pharmaceutical Ggrade Probiotics Price (US$/MT) by Application (2019-2030)
    Figure 60. Pharmaceutical Ggrade Probiotics Value Chain
    Figure 61. Pharmaceutical Ggrade Probiotics Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions